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Abstract
Background: Neutrophils are the first line of defense against invasive microorganisms during and after surgery.
There is a possibility that different opioid analgesics used during surgery have different effects on the leucocyte
count. We retrospectively analyzed the numbers of leucocytes, neutrophils, and lymphocytes just after surgery
in patients who received remifentanil-based anesthesia and those who received fentanyl-based anesthesia.
In female patients who underwent modified mastectomy or simple mastectomy with resection of a lymph node(s)
or with biopsy of a sentinel lymph node(s) between January 2010 and December 2013 (n = 83), propensity score
pairwise matching was performed according to the patient’s age and procedure, and forty patients (Remifentanil
group and Fentanyl group; n = 20 each) were analyzed.
Findings: Postoperative numbers of leucocytes and neutrophils were significantly lower in patients who received
remifentanil-based anesthesia than in those who received fentanyl-based anesthesia (p = 0.03, p = 0.014; leucocytes
and neutrophils, respectively). The increases in the numbers of leucocytes and neutrophils were significantly lower
in the patients in the remifentanil group (p = 0.009, p = 0.0046; increase in leucocytes and neutrophils, respectively).
Conclusions: In conclusion, remifentanil-based anesthesia attenuates postoperative leucocyte and neutrophil
counts. It is unknown whether this phenomenon indicates the possibility of immunosuppression. Further studies
are required.
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Introduction
Neutrophils are the first line of defense against invasive
microorganisms during and after surgery. The numbers
of leucocytes, neutrophils and lymphocytes may change
in response to surgery due to various hormones, cyto-
kines and acute phase reactants [1].
Neutrophils are produced within hematopoietic cords
interspersed within venous sinuses of the bone marrow,
and the number of circulating neutrophils is maintained
by a fine balance among granulopoiesis, bone marrow
storage and release, intravascular margination, clearance,
apoptosis and destruction [2]. The principal regulator of
granulopoiesis is granulocyte colony stimulating factor
(G-CSF) [3]. Interleukin (IL)-6 and IL-8 are also known to
promote neutrophil production in vitro and in vivo [4, 5].
The production of immune mediators is associated
with the extent of surgical trauma, and is also influenced
by the anesthesia technique [6, 7]. Remifentanil is a
newly developed analgesic that possesses extremely rapid
clearance. An in vitro study suggested that remifentanil
decreased expression of inflammatory cytokines such as
TNF-α, IL-6 and IL-8 induced by lipopolysaccharide
(LPS) in human neutrophils [8].
These results suggest that the different opioid analge-
sics used during surgery may have different effects on
the leucocyte count. We retrospectively analyzed the
numbers of leucocytes, neutrophils, and lymphocytes
just after surgery in patients who received remifentanil-
based anesthesia and those who received fentanyl-based
anesthesia.
Methods
The records of female patients who underwent modified
mastectomy or simple mastectomy with resection of a
lymph node(s) or with biopsy of a sentinel lymph
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node(s) between January 2010 and December 2013 were
retrospectively investigated. This study was approved by
the ethics committee of Musashikosugi Hospital Nippon
Medical School. Exclusion criteria included patients who
received chemotherapy before surgery, patients who pre-
sented with a febrile symptom before the surgery (C-re-
lated protein >0.3), and patients over the age of 75 years.
Patients whose surgery lasted less than 80 min or longer
than 181 min were excluded.
The following data were collected and compared be-
tween the patients who received remifentanil-based
anesthesia and those who received fentanyl-based
anesthesia: patients’ age, height, weight, duration of sur-
gery, amount of infusion, blood loss, and total amount
of opioid analgesic (fentanyl, remifentanil, or both) ad-
ministered during surgery. The systolic blood pressure
before the surgery, highest systolic blood pressure dur-
ing surgery, systolic blood pressure just after the surgery,
and heart rates at the respective systolic blood pressure
were recorded. The mean infusion rate of remifentanil
(μg/kg/h) was calculated by dividing the total amount of
remifentanil administered by the patient’s weight and
the duration of the surgery. Preoperative and postopera-
tive counts of leucocytes, neutrophils and lymphocytes
were recorded. The increases in numbers of leucocytes,
neutrophils, and lymphocytes were calculated by sub-
tracting the preoperative value from the respective post-
operative value. Patients who received additional pain
medicine (e.g., NSAIDs) were noted.
Statistical analysis
To reduce the selection bias on the number of immune
cells, we performed a propensity score pairwise match-
ing of patients maintained with remifentanil with pa-
tients maintained with fentanyl, using patient’s age and
procedure. As the propensity score-matched analysis
was selected to reduce preoperative confounding factors,
the propensity score was constructed with the aid of a
logistic regression model using preoperative variables.
Patients maintained with remifentanil whose propensity
Table 1 Characteristics of the patients who received remifentanil-based anesthesia or fentanyl-based anesthesia
Remifentanil (n = 47) Fentanyl (n = 36) P value
Age (y) 57 ± 11 51 ± 10 0.025
Height (cm)a 156 ± 6 154 ± 7 0.21
Weight (kg)a 55 ± 8 55 ± 10 0.98
Mastectomy: partial mastectomy 26:21 13:23 0.39
SLNB or RLNb 23:24 21:15 0.08
Received flubiprofen 19 15 0.9
Total amount of remifentanil (μg/kg)a 23.5 ± 11.4 0 ± 0 <0.0001
Total amount of fentanyl (μg/kg)a 2.2 ± 2.8 5.5 ± 2.5 <0.0001
Duration of surgery (min)a 111 ± 33 122 ± 30 0.1
Mac-hour(h) 2.1 ± 0.5 2.6 ± 0.7 0.01
Total amount of ephedrine (mg) 3 ± 3.8 1.3 ± 2.2 0.06
Number of Patients received ephedrine (n) 21 12 0.36
Blood pressure (mmHg) Preope 144 ± 24 139 ± 25 0.36
Highest 122 ± 17 131 ± 18 0.019
Lowest 82 ± 7 88 ± 10 0.0024
Postope 133 ± 17 133 ± 24 0.95
Heart rate (b/min) Preope 73 ± 13 70 ± 13 0.35
At highest BP 61 ± 9 64 ± 10 0.14
At lowest BP 55 ± 7 56 ± 7 0.42
Postope 74 ± 12 72 ± 14 0.43
Total amount of infusion (ml)a 1250 ± 385 1325 ± 390 0.4
Preoperative leucocyte count (/μl)a 5726 ± 1656 5536 ± 1405 0.63
Preoperative neutrophil count (/μl)a 3270 ± 1230 3210 ± 1215 0.83
Preoperative lymphocyte count (/μl)a 1910 ± 690 1820 ± 545 0.51
Preoperative monocyte count (/μl)a 260 ± 80 270 ± 110 0.64
aMean ± SD
bSLNB sentinel lymph node biopsy, RLN resection of lymph node
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scores deviated by >0.02 from those of patients main-
tained with fentanyl, were considered unmatched.
Results are shown as mean ± standard deviation. The
significance of differences in categorical values and nu-
merical values were analyzed using chi-squared test and
unpaired t-test, respectively. The correlation between
numerical parameters was analyzed using linear regres-
sion analysis. Significance was set at p < 0.05.
Results
Eighty-three patients underwent modified mastectomy
or simple mastectomy with resection of a lymph node or
with biopsy of a sentinel lymph node met the study cri-
teria. Of these, 36 patients received fentanyl-based
anesthesia and 47 patients received remifentanil-based
anesthesia. All patients received propofol and rocuro-
nium, and trachea was intubated. Anesthesia was main-
tained by sevoflurane, propofol had not been used for
maintenance. Blood samples had been obtained within
2 h after emergence from anesthesia in all patients. The
characteristics of the patients who received remifentanil-
based anesthesia or fentanyl-based anesthesia are summa-
rized in Table 1. After propensity matching, we obtained
40 patients for analysis, which included 20 patients in the
remifentanil group who received remifentanil-based
anesthesia, and 20 patients in the fentanyl group who re-
ceived fentanyl-based anesthesia. No patients in neither
fentanyl nor remifentanil group developed problem in
wound healing process such as surgical site infection. No
patients received catecholamine as inotropes, only ephe-
drine had been used. As shown in Table 2, there is no dif-
ference in number of patients who received ephedrine and
in amount of ephedrine. Postoperative numbers of leuco-
cytes and neutrophils were significantly lower in remifen-
tanil group than fentanyl group (leucocytes, 7521 ± 2492
vs. 5873± 2123, p = 0.03; neutrophils, 5098± 1964 vs.
3499 ± 1970, p = 0.014) (Fig. 1). There was no significant
difference in the number of lymphocytes between the two
Table 2 Characteristics of the patients who received remifentanil-based anesthesia or fentanyl-based anesthesia after propensity
matching
Remifentanil group (n = 20) Fentanyl group (n = 20) P value
Age (y) 54 ± 11 52 ± 12 0.68
Height (cm)a 157 ± 7.5 152 ± 5 0.38
Weight (kg)a 54 ± 9 56 ± 11 0.58
Mastectomy: partial mastectomy 5:15 6:14 0.72
SLNB or RLNb 19:1 18:2 0.54
Received flubiprofen 19 15 0.9
Total amount of remifentanil (μg/kg)a 20.1 ± 9.4 0 ± 0 <0.0001
Total amount of fentanyl (μg/kg)a 1.9 ± 1.9 5.4 ± 2.1 <0.0001
Duration of surgery (min)a 94 ± 23 103 ± 20 0.14
MAC-hour(h) 2.2 ± 0.5 2.7 ± 0.7 0.01
Total amount of ephedrine (mg) 3 ± 3.5 1.2 ± 2.1 0.06
Number of Patients received ephedrine (n) 9 5 0.32
Blood pressure (mmHg) Preope 137 ± 20 139 ± 24 0.8
Highest 116 ± 15 135 ± 17 0.0016
Lowest 80 ± 7 87 ± 10 0.02
Postope 130 ± 16 134 ± 25 0.64
Heart rate (b/min) Preope 76 ± 16 69 ± 12 0.10
At highest BP 63 ± 10 65 ± 11 0.22
At lowest BP 55 ± 7.5 56 ± 7.5 0.8
Postope 74 ± 15 72 ± 10 0.48
Total amount of infusion (ml)a 1235 ± 290 1360 ± 460 0.3
Preoperative leucocyte count (/μl)a 5460 ± 1460 5622 ± 1587 0.74
Preoperative neutrophil count (/μl)a 3169 ± 1192 3274 ± 1264 0.78
Preoperative lymphocyte count (/μl)a 1845 ± 663 1857 ± 619 0.95
Preoperative monocyte count (/μl)a 265 ± 81 267 ± 106 0.94
aMean ± SD
bSLNB sentinel lymph node biopsy, RLN resection of lymph node
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Fig. 1 Comparison of the postoperative numbers of leucocytes (black bar), neutrophils (gray bar) and lymphocytes (white bar) between the
patients who received fentanyl-based anesthesia (n = 20) and those who received remifentanil-based anesthesia (n = 20). The leucocyte count
(a: p = 0.03) and neutrophil count (b: p = 0.014) were significantly lower in patients who received remifentanil-based anesthesia than in those who
received fentanyl-based anesthesia. Error bars represent the standard deviation. There was no significant difference in the number of lymphocytes
between the two groups (c: p = 0.92)
Fig. 2 Correlations between the postoperative neutrophil count and duration of surgery in fentanyl group (thick line and dark shadow), and
between the postoperative neutrophil count and duration of surgery in remifentanil group (dotted line and light shadow). The dark shadow
represents the 95 % confidence interval (CI) in fentanyl group and the light shadow represents the 95 % CI in remifentanil group. Neutrophil
count =5335-2.2*duration of surgery (min). R2 = 0.00, P = 0.92 (Fentanyl group). Neutrophil count = -1349 + 51.8*duration of surgery (min).
R2 = 0.36, P = 0.0044 (Remifentanil group)
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groups (Fig. 1). Among the 20 patients in the remifentanil
group, 13 patients received additional fentanyl. In the
remifentanil group, there were no differences in the num-
bers of leucocytes, neutrophils and lymphocytes between
the patients who received additional fentanyl and those
who did not. The postoperative number of of neutrophils
was correlated with the duration of surgery only in the
remifentanil group (R2 = 0.36, p = 0.004) (Fig. 2).
Discussion
In the present study, we observed that postoperative
counts of leucocytes and neutrophils were significantly
lower in the patients who received remifentanil-based
anesthesia than in those who received fentanyl-based
anesthesia. Because the number of lymphocytes and in-
crease in the number of lymphocytes from the preopera-
tive value did not differ between those who received
remifentanil-based anesthesia and those who received
fentanyl-based anesthesia, the difference in the number
of leucocytes may be mainly due to the kinetics of
neutrophils.
One explanation for why the neutrophil count was
higher in the fentanyl group is an increase in release of
neutrophils from bone marrow by inflammatory cyto-
kines in the fentanyl group. Terashima et al. [9] demon-
strated that administration of IL-8 rapidly increased the
numbers of granulocytes and polymorphonuclear leuko-
cytes without affecting transit time through both the
mitotic and post-mitotic pools of bone marrow. In
addition to G-CSF, IL-6 and IL-3 stimulate granulopoi-
esis in vivo [10]. Remifentanil attenuates expression of
pro-inflammatory cytokines including TNF-α, IL-6, and
IL-8 in vitro [8]. Another in vitro study demonstrated
decreased neutrophil transmigration through the endo-
thelial cell monolayer by co-incubation with remifentanil
[11], and this suggests that a smaller number of neutro-
phils migrated to damaged tissue from microvessels in
the remifentanil group than in the fentanyl group. The
possibility that a low number of neutrophils reached
damaged tissue in the remifentanil group suggests that
the amount of cytokines released from neutrophils re-
cruited in the damaged site may have been lower in the
remifentanil group than in the fentanyl group. Among
patients who underwent cardiac surgery, patients who
received fentanyl-based anesthesia had a higher level of
stress hormone and higher levels of proinflammatory cyto-
kines compared with patients who received remifentanil-
based anesthesia [12]. In the present study, the numbers of
leucocytes and neutrophils were both correlated with the
duration of surgery among the patients in the remifentanil
group. Long duration of surgery may be related to surgical
stress. In the present study, one possible reason for the
difference in the number of neutrophils between the remi-
fentanil group and fentanyl group is a difference in
production of neutrophils in bone marrow introduced by
differences in surgical stress and inflammatory cytokines.
There have only been a few studies on the relationship
between remifentanil and immunosuppression. Studies
in vitro demonstrated that high-dose remifentanil sup-
presses the release of cytokines from neutrophils and
monocytes that had been stimulated by LPS [8]. Very low-
dose remifentanil did not suppress NK-cell activity in
healthy human volunteers [13]. A study in rats demon-
strated that continuous infusion of remifentanil inhibited
the proliferation of splenocytes induced by concanava-
lin A [14]. Although the reductions in the elevation of
leucocytes and neutrophils in the remifentanil group
may have been related to reduction in the proliferation
of neutrophils, whether suppression of increases in the
numbers of leucocytes and neutrophils directly causes
immunosuppression is unknown. General anesthetic agents
induce different inflammatory responses [6, 7]. Sevoflurane
has a smaller effect on the neutrophil count than des-
flurane [7]. The Mac-hour of sevoflurane in the remi-
fentanil group was significantly lower than that in the
fentanyl group, although the difference was very small.
We believe that the effect of sevoflurane on the results
may have been small.
In conclusion, remifentanil-based anesthesia attenuated
postoperative leucocyte and neutrophil counts. It is un-
known whether this phenomenon indicates the possibility
of immunosuppression. Further studies are required.
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